Vyvanse Leaks: The Government's Response

Sep 4, 2024 · the u. s. Drug enforcement administration has increased the production limit for takeda pharmaceutical's adhd drug vyvanse and its generic versions by about 24% to. Nov 17, 2023 · a us shortage of the new generic version of vyvanse, an adhd medication, is due in part to federal limits on production, according to an industry group representing generic. Sep 6, 2024 · the drug enforcement administration is increasing the production limit of vyvanse and its generic equivalents by about 24% to address the ongoing global shortage of adhd. Sep 5, 2024 · the u. s.

Sep 6, 2024 · while supplies of adderall and its generic versions are finally recovering after a yearslong shortage, the drug enforcement administration is now working to curb the short. Drug enforcement administration to make more of the medication.